Potassium Chloride

Product NDC: 50090-5335
11-digit product format: 500905335
Labeler code: 50090
Product ID: 50090-5335_dbf5cc65-196b-4d7c-a311-d30c7d9fef63
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Potassium Chloride
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA210921
Marketing category: ANDA
Marketing start: 2018-12-19
Substance: POTASSIUM CHLORIDE
Active strength: 750 mg/1
Pharmacologic classes: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A210921-001	POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2		2018-12-19
A210921-002	POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2		2018-12-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A210921-001	AB2
A210921-002	AB2

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A210921-001	POTASSIUM CHLORIDE	8MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A210921-002	POTASSIUM CHLORIDE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB2	2018-12-19	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A210921-001	AB2	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210921-002	AB2	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210921-001	AB2	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210921-002	AB2	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210921-001	AB2	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210921-002	AB2	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210921-001	AB2	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210921-002	AB2	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210921-001	AB2	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210921-002	AB2	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210921-001	AB2	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210921-002	AB2	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210921-001	AB2	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210921-002	AB2	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210921-001	AB2	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210921-002	AB2	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210921-001	AB2	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210921-002	AB2	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210921-001	AB2	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210921-002	AB2	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210921-001	AB2	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210921-002	AB2	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210921-001	AB2	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210921-002	AB2	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210921-001	AB2	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210921-002	AB2	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210921-001	AB2	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A210921-002	AB2	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210921-001	AB2	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210921-002	AB2	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210921-001	AB2	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A210921-002	AB2	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210921-001	AB2	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A210921-002	AB2	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A210921-001	AB2	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A210921-002	AB2	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A210921-001	AB2	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A210921-002	AB2	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A210921-001	AB2	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A210921-002	AB2	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Potassium Chloride
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
POTASSIUM CHLORIDE	750 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
660YQ98I10	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
628953	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e1670127-c551-441b-bac4-39f10a6d156f	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
d9771140-739b-484b-ae64-b79528ff1211	Product name	3	20250801
efd58dcf-540a-4531-8766-e713129ca6f2	Product name	1	20250307
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50090-5335-0	2023-02-06	These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948
50090-5335-1	2023-02-06	These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948
50090-5335-2	2023-02-06	These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948
50090-5335-3	2023-02-06	These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948
50090-5335-0	2023-01-30	These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948
50090-5335-1	2023-01-30	These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948
50090-5335-2	2023-01-30	These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948
50090-5335-3	2023-01-30	These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50090-5335-0	Potassium Chloride	30 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	30	9
50090-5335-1	Potassium Chloride	100 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	100	9
50090-5335-2	Potassium Chloride	90 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	90	9
50090-5335-3	Potassium Chloride	60 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	60	9

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-5335-0	EA - Each	50090-5335	ab7b6574-69a1-43ba-95fd-1052fae57147	1	2023-02-06
50090-5335-1	EA - Each	50090-5335	45b5bb8f-a2c5-49d0-bfff-c43b155074b8	1	2023-02-06
50090-5335-2	EA - Each	50090-5335	64e05bf4-8e2e-45d6-9af0-fc49016ec358	1	2023-02-06
50090-5335-3	EA - Each	50090-5335	7797be17-d069-48c7-8b82-08f229361b4b	1	2023-02-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-5335	POTASSIUM CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS]	9	Current NDC, Legacy NDC, 4 package rows	20230919_e1670127-c551-441b-bac4-39f10a6d156f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Potassium Chloride	POTASSIUM CHLORIDE	REMEDYREPACK INC.	16c775e4-0dd8-4e9f-b2bf-dd2b639374cf	2026-07-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921
Potassium Chloride	POTASSIUM CHLORIDE	Bryant Ranch Prepack	9088ca44-5585-4551-8e2c-168f306520d4	2026-03-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921
Potassium Chloride	POTASSIUM CHLORIDE	Northwind Health Company, LLC	f3081031-8234-5732-e053-2995a90aebeb	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921
Potassium Chloride	POTASSIUM CHLORIDE	Major Pharmaceuticals	a9d68a40-75e3-4c5c-b5d7-1d6160527fa7	2025-09-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921
Potassium Chloride	POTASSIUM CHLORIDE	Preferred Pharmaceuticals Inc.	3f19ed0e-6c73-482c-94d6-d3205318fd6f	2025-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921
Potassium Chloride	POTASSIUM CHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	3dfa63fc-f8de-f1e0-e063-6294a90a8d47	2025-09-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921
Potassium Chloride	POTASSIUM CHLORIDE	American Health Packaging	a67f5ba7-ac23-4bdc-9563-cb7fd049a951	2024-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921
Potassium Chloride	POTASSIUM CHLORIDE	A-S Medication Solutions	e1670127-c551-441b-bac4-39f10a6d156f	2023-09-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921 ndc (product): 50090-5335
Potassium Chloride	POTASSIUM CHLORIDE	BluePoint Laboratories	73c911bb-4d39-4793-acba-90ed4b0eff46	2022-10-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921
Potassium Chloride	POTASSIUM CHLORIDE	Aurobindo Pharma Limited	d43beabe-b801-4319-ad36-9a80856b94bd	2021-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210921 application number: ANDA210921

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
660YQ98I10	POTASSIUM CHLORIDE	7447-40-7	POTASSIUM CHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
628953	potassium chloride 10 MEQ (750 MG) Extended Release Oral Tablet	PSN	e1670127-c551-441b-bac4-39f10a6d156f	9
628953	potassium chloride 10 MEQ Extended Release Oral Tablet	SCD	e1670127-c551-441b-bac4-39f10a6d156f	9
628953	K+ Chloride 10 MEQ Extended Release Oral Tablet	SY	e1670127-c551-441b-bac4-39f10a6d156f	9
628953	Pot Chloride 10 MEQ Extended Release Oral Tablet	SY	e1670127-c551-441b-bac4-39f10a6d156f	9
628953	potassium chloride 750 MG (potassium 10 mEq) Extended Release Oral Tablet	SY	e1670127-c551-441b-bac4-39f10a6d156f	9
628953	potassium chloride 750 MG Extended Release Oral Tablet	SY	e1670127-c551-441b-bac4-39f10a6d156f	9

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-5335-0	50090533500	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-5335-0)	2020-11-04	0000-00-00	No	No	Current
50090-5335-1	50090533501	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-5335-1)	2020-11-04	0000-00-00	No	No	Current
50090-5335-2	50090533502	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-5335-2)	2020-11-04	0000-00-00	No	No	Current
50090-5335-3	50090533503	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-5335-3)	2020-11-04	0000-00-00	No	No	Current